The workshop will bring together key stakeholders including industry, academia, regulators, patients, clinicians, funders and commissioners to discuss and identify ways to overcome the challenges associated with selecting study endpoints in oncology, and consider those outcomes that are important for clinical trial measures to be ‘fit for purpose’, now and in the future.
“I want to run a great trial – how do I do it?” will be presented by Pamela Kearns and Peter Brocklehurst. The session will last for one hour and will give the opportunity to ask questions and generate new ideas.
The aims of this conference are to share current and recent research undertaken by Birmingham City University and its strategic partners, raise awareness of the short and long term consequences of premature birth and develop a shared interdisciplinary understanding of how to support children and families in the current socio-political-economic climate.
At this event, the public health wider impact on issues of employment and unemployment for people who are blind and partially sighted will be considered. Speakers from the third sector will consider the problems and opportunities and speakers from local and national public health organisations will consider the wider societal impact. You will also hear from those with lived experience of visual impairment and employment/unemployment.
The WMAHSN invites you to attend their Annual Stakeholder Event and Awards, which takes place at the Hilton Birmingham Metropole on Thursday 20 July 2017. The plenary session will bring to life the 2016-17 Annual Report, and there will also be an exhibition, offering the opportunity to network with the shortlisted organisations. Following the plenary session and networking, this year’s Celebration of Innovation Awards will be presented at the awards dinner.